Poltreg logo — Harnessing groundbreaking TREG therapy for global health inn...

Poltreg

Harnessing groundbreaking TREG therapy for global health innovation.

Founded 2015 Grant Total: $50.00K Biotechnology, Health Care +1

General Information

Company Name Poltreg
Founded Year 2015
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Poltreg. To contact Poltreg, visit poltreg.tech.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Poltreg

Poltreg is a biotechnology startup that harnesses groundbreaking TREG therapy for global health innovation. Originating as a spin-off from the Medical University of Gdańsk, the company is dedicated to developing and commercializing the patented TREG method. With promising results from clinical trials at the University Clinical Center in Gdańsk, Poltreg is committed to making this innovative therapy accessible to a wider patient base. Founded in 2015, the company has seen significant progress in the two years leading up to its formal launch, largely due to an extensive collaboration with the University and research team, shaping its business model, commercialization strategy, and legal protections. Furthermore, Poltreg holds exclusive rights to apply the research findings concerning T-regulatory lymphocytes and their cultivation methods for clinical applications. The company's last investment of €50.00K came in the form of a grant investment on 01 July 2016, provided by EASME - EU Executive Agency for SMEs. With its strategic focus on biotechnology, health care, and health and wellness, Poltreg emerges as a promising player in the field, poised for potential growth and impact in the coming years.

Taxonomy: medical innovation, clinical trials, TREG therapy, University spin-off, research commercialization, patent licensing, medical research, University collaboration, startup funding, innovation management

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €50.00K 1
EASME - EU Executive Agency for SMEs
01 Jul 2016
Seed Round Undisclosed 1
INNOventure
04 Dec 2015

Poltreg Alternatives & Competitors

Poltreg vs

Pioneering Innovation in Cardiac Stress Diagnostics

Venture round
11-50 employees
Biotechnology, Health Care
Poltreg vs

Developing the next generation bacterial cancer therapy

Grant
25 employees
Biotechnology, Health and Wellness
Poltreg vs

Pioneering Next-Generation Vaccination Solutions for a Healthier Future

Venture round
11-50 employees
Biotechnology, Health and Wellness

FAQ About Poltreg

Harnessing groundbreaking TREG therapy for global health innovation.
Poltreg was founded in 2015.
Poltreg operates in Biotechnology, Health Care and Health and Wellness. Its work centres on medical innovation, clinical trials, TREG therapy and University spin-off.
Poltreg has completed 2 funding rounds, raising a total of $50.00K. The latest funding stage is Grant.
Top alternatives and competitors to Poltreg include Adenosine Therapeutics, T3 Pharmaceuticals AG, BigDNA, osteolabs GmbH, Micrima Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Poltreg and Adenosine Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Poltreg, https://bouncewatch.com/company/poltreg, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes